[1] DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019 [J]. CA Cancer J Clin, 2019, 69(6): 438-451.
[2] Roumeliotis GA, Dostaler G, Boyd KU. Complementary and alternative medicines and patients with breast cancer: a case of mortality and systematic review of patterns of use in patients with breast cancer [J]. Plast Surg (Oakv), 2017, 25(4): 275-283.
[3] O’Grady S, Morgan MP. Microcalcifications in breast cancer: from pathophysiology to diagnosis and prognosis [J]. Biochim Biophys Acta Rev Cancer, 2018, 1869(2): 310-320.
[4] Guttman M, Amit Ⅰ, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large noncoding RNAs in mammals [J].Nature, 2009, 458(7235): 223-227.
[5] Sanchez Calle A, Kawamura Y, Yamamoto Y, et al. Emerging roles of long non-coding RNA in cancer [J]. Cancer Sci, 2018,109(7): 2093-2100.
[6] Strausberg RL, Feingold EA, Grouse LH, et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences [J]. Proc Natl Acad Sci USA, 2002, 99(26): 16899-16903.
[7] Kimura K, Wakamatsu A, Suzuki Y, et al. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes [J]. Genome Res, 2006, 16(1): 55-65.
[8] Luo L, Yang R, Zhao S, et al. Decreased miR-320 expression is associated with breast cancer progression, cell migration, and invasiveness via targeting Aquaporin 1 [J]. Acta Biochim Biophys Sin (Shanghai), 2018, 50(5): 473-480.
[9] Wei M, Yu HL, Cai CX, et al. Construction of the AQP1 3’-UTR dual luciferase reporter vector and validation of the targeted relation with miR-204 [J]. Biotechnology,2019, 29(4): 324-329. (in Chinese)
危敏, 余海浪, 蔡翠霞, 等. 双荧光素酶报告系统鉴定miR-204对水通道蛋白1基因的调控作用 [J]. 生物技术, 2019, 29(04): 324-329.
[10] Liu DT, Yang ZhJ, Ding B, et al. Effects of microRNA-4286 on the growth,migration and invasion of gastric cancer cell line HGC-27 by regulating inositol polyphosphate-4-phosphatase typeⅠ[J]. Acta Anatomica Sinica,2021,52(3):405-409. (in Chinese)
刘东涛,杨志娟,丁波,等.微小RNA-4286调控肌醇多聚磷酸-4-磷酸酶Ⅰ型对胃癌细胞系HGC-27生长、迁移及侵袭的影响[J].解剖学报, 2021,52(3):405-409.
[11] Ma Zh,Jiang ZhX,Jiang Zh. Effect of PHLDA2 on proliferation, migration, invasion and apoptosis in hepatocellular carcinoma cells [J]. Acta Anatomica Sinica,2020,51(3):398-404.
马战,姜钟翔,姜政.PHLDA2对肝癌细胞的增殖、侵袭、迁移和凋亡的影响[J].解剖学报, 2020,51(3):398-404.
[12] Kopp F, Mendell JT. Mendell, functional classification and experimental dissection of long noncoding RNAs [J]. Cell, 2018, 172(3): 393-407.
[13] Chen X, Fan S, Song E. Noncoding RNAs: new players in cancers [J]. Adv Exp Med Biol, 2016, 927: 1-47.
[14] Prabhu KS, Raza A, Karedath T, et al. Non-coding RNAs as regulators and markers for targeting of breast cancer and cancer stem cells [J]. Cancers (Basel), 2020, 12(2):351.
[15] Pareja F, Reis-Filho JS. Triple-negative breast cancers - a panoply of cancer types [J]. Nat Rev Clin Oncol, 2018, 15(6): 347-348.
[16] Du Z, Gao W, Sun J, et al. Identification of long noncoding RNAmediated transcriptional dysregulation triplets reveals global patterns and prognostic biomarkers for ER+/PR+, HER2 and triple negative breast cancer [J]. Int J Mol Med, 2019, 44(3): 1015-1025.
[17] Thomson DW, Dinger ME. Dinger, Endogenous microRNA sponges: evidence and controversy [J]. Nat Rev Genet, 2016, 17(5): 272-283.
[18] Tay Y, Kats L, Salmena L, et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs [J]. Cell, 2011,147(2): 344-357.
[19] Poliseno L, Salmena L, Zhang J, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology [J]. Nature, 2010, 465(7301): 1033-1038.
[20] Shi L, Hong X, Ba L, et al. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression [J]. Cell Death Dis, 2019, 10(3): 150.
[21] Piwecka M, Gla?ar P, Hernandez-Miranda LR, et al. Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function [J]. Science, 2017, 357(6357): eaam8526.
[22] Zhang T, Zou P, Wang T, et al. Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer [J]. Tumour Biol, 2016, 37(7): 8931-8940.
[23] Zhao H, Dong T, Zhou H, et al. miR-320a suppresses colorectal cancer progression by targeting Rac1 [J]. Carcinogenesis, 2014, 35(4): 886-895.
[24] Hsieh IS, Chang KC, Tsai YT, et al. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway [J]. Carcinogenesis, 2013, 34(3): 530-538.
[25] Sun JY, Huang Y, Li JP, et al. MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting beta-catenin [J]. Biochem Biophys Res Commun, 2012, 420(4): 787-792.
[26] Schaar DG, Medina DJ, Moore DF, et al. miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation [J]. Exp Hematol, 2009, 37(2): 245-255.
[27] Tadano T, Kakuta Y, Hamada S, et al. MicroRNA-320 family is downregulated in colorectal adenoma and affects tumor proliferation by targeting CDK6 [J]. World J Gastrointest Oncol, 2016, 8(7): 532-542.
[28] Trimboli AJ, CantemirStone CZ, Li F, et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours [J]. Nature, 2009, 461(7267): 1084-1091.
|